Phospholipase‐A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy

BACKGROUND: We aimed to evaluate cyclophosphamide efficacy in the treatment of idiopathic membranous nephropathy (IMN) and explore the efficacy of phospholipase‐A2 receptor antibody (PLA2R‐Ab), 24 hours proteinuria, and serum albumin in predicting 6‐ and 12‐month treatment effects. METHODS: A retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Chunying, Liu, Yong, Zhang, Xinpeng, Luo, Lin, Li, Xiaoying, Wang, Tingting, Tian, Zhe, Qin, Xiaosong, Liu, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521260/
https://www.ncbi.nlm.nih.gov/pubmed/32449206
http://dx.doi.org/10.1002/jcla.23368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521260/
https://www.ncbi.nlm.nih.gov/pubmed/32449206
http://dx.doi.org/10.1002/jcla.23368

Ejemplares similares